Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. Merck and Co. Integration is key.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

FEBRUARY 3, 2017

The business model of research-based pharmaceutical companies is under significant pressure. It’s a fact that the current business model of pharma companies is not working efficiently. This represents a disquieting trend for companies whose profit growth heavily depends on price increases.

Reputation 8

Reputation Pharmaceuticals Price Business Model 8

Harvard Business Review

JANUARY 29, 2014

He mentioned a number of themes that we cover regularly here at HBR: the minimum wage, inequality, women in the workplace, manufacturing, and health care to name just a few. Health Care Costs. On the latter topic, check out Michael Porter and Thomas Lee, who lay out a strategy for improving the health care industry.

Insourcing 8

Insourcing Health Care Proposal Meyer 8

Harvard Business Review

JULY 11, 2018

We need to start preparing for a new era of innovation in which different technologies, such as genomics, materials science, and robotics , rise to the fore. First, people need to change their habits, and then secondary innovations need to come into play. These efforts are already greatly increasing our ability to innovate.

Industry 10

Industry GDP Technology Agility 10

Harvard Business Review

JUNE 27, 2017

Today some companies are taking brand anthropomorphism to a whole new level with sophisticated AI technologies. And over time Siri, Alexa, and Cortana, and their individual “personalities,” could become even more famous than their parent companies. The implications are numerous.

Brand 8

Brand Disintermediation Ethics Technology 8

Harvard Business Review

JUNE 9, 2017

The Leading Edge of Health Care. How the most innovative providers are creating value. National Institutes of Health, but the reverse is less clear; biopharmaceutical companies, too, participate in basic research that advances our understanding of mechanisms of disease and treatment. Insight Center.

Conflict of Interest 8

Conflict of Interest Pharmaceuticals Policies Industry 8

Harvard Business Review

JULY 12, 2011

The front page of yesterday's New York Times offered an in-depth account of how innovators in one industry are wrestling with that very question. The process "has enormous consequences" not for just for aspiring doctors, the Times says, but "also for the entire health care system.". Here's what the fuss is about.

Airlines 15

Airlines Health Care Consensus Policies 15

Harvard Business Review

JANUARY 20, 2012

No, the real story here is the willingness so many companies displayed — Wikipedia going dark; Google's logo blackout — to irk, irritate and/or annoy their users into awareness about a cause that infuriated them. What a novel twist to that famous saying that "people don't care how much you know until they know how much you care."

Tactics 13

Tactics Self-aware Politics Industry 13

Harvard Business Review

JULY 14, 2017

presidential election, Interpublic (IPG), my company’s parent corporation, held its first open call for employees to talk about concerns related to respect in the workplace. ” Companies today have the capacity to be a haven from the incivility that individuals confront every day, on the road, online, in the media, and in politics.

Diversity 8

Diversity Politics Survey Incubator 8

Harvard Business Review

MAY 3, 2013

Suddenly, companies and consumers across the world are finding themselves in a moral quandary: How can you make (or purchase) clothing cheaply without compromising supply-chain ethics? One company, however, had decided to leave Bangladesh prior to the collapse: Disney. You Want Me to Innovate Where?

Supply Chain 8

Supply Chain Health Care Letter Globalization 8

Harvard Business Review

JUNE 12, 2012

The United States is home to some of the key pioneers of Technik whose innovations help society adapt to the future. Those companies' hardware and software platforms are the foundation for almost endless innovation by diverse users worldwide, a contribution no Europeans or Asians can match.

First-mover Advantage 8

First-mover Advantage GDP Technology Biotechnology 8

Harvard Business Review

OCTOBER 6, 2011

The perception has been eroding our industry's image and has caused many in our industry to assume that R&D, innovation, and social contribution are unaffordable luxuries in a fiercely cost-based competitive game. This philosophy has started to take its toll.

Industry 10

Industry Strategy Supply Chain Long-term 10